Distinct alterations in lineage committed progenitor cells exist in the peripheral blood of patients with rheumatoid arthritis and primary Sjögren's syndrome

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 439-446

  Santiago Schwarz, Frances ^a,b   Sullivan, Catherine ^a   Rappa, Deborah ^b   Carsons, Steven E ^b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Cytokines; Dendritic cells; Primary Sj gren's syndrome; Progenitors; Rheumatoid arthritis

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEM CELL FACTOR; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME;

ADP-RIBOSYL CYCLASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARTHRITIS, RHEUMATOID; BONE MARROW; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; N-GLYCOSYL HYDROLASES; NEPRILYSIN; RECEPTORS, TRANSFERRIN; SJOGREN'S SYNDROME; STEM CELL FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029943784     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ziff M: Pathways of mononuclear cell infiltration in rheumatoid synovitis. Rheumatol Int 1989;9:91-103.
2. Fox RI, Lotz M, Carson DA: Structure and function of synoviocytes. Scientific Basis for The Study Of The Rheumatic Diseases. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions, 12th ed., Philadelphia: Lea and Febiger, 1993.
3. Firestein GS, Zvaifler N: Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. Arthritis Rheum 1957,30:857-63.
4. Athanasou NA, Quinn J: Immunocytochermcal analysis of human synovial lining cells: phenotypic relation to other marrow derived cells. Ann Rheum Dis 1991;50.311-5.
5. Pitzalis C, Kingsley G, Murphy D, Panazi G: Abnormal distribution of the helper-inducer and suppressor-inducer T lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 1987;42:252-8.
6. Wood NC, Dickens E, Symons JA, Duff GW: In situ hybridization of interleukin-1 in CDI4-positive cells in rheumatoid arthritis. Clin Immunol Immunopathol 1992;62:3:295-300.
7. Hanly JG, Pledger D: Characteristics of immunocompetent cells in synovial membranes from multiple sites in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:1066-8.
8. Kaul A, Blake DR, Pearson JD: Vascular endothelium, cytokines, and the pathogenesis of inflammatory synovitis. Ann Rheum Dis 1991;50:828-32.
9. Cush JJ, Pietschmann P, Oppenheimer-Marks N, Lipsky PE: The intrinsic migratory capacity of memory T-cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum 1992;35:1434-44.
10. Feldmann M, Brennan FM, Chantry D, et al.: Cytokine assays: Role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 1997;119:105-23.
11. Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:3:305-15.
12. Ochi T, Hakomori S-I, Adachi M, et al.: The presence of a myeloid cell population showing strong reactivity with monoclonal antibody directed to difucosyl Type 2 chain in epiphyseal bone marrow adjacent to joints affected with rheumatoid arthritis (RA) and its absence in the corresponding normal and non-RA bone marrow. J Rhewnatol 1988;15:1609-15
13. Owaki H, Ochi T, Yamasaki K, Yukawa K, Wakitani S, Okamura M Ono K: Elevated activity of myeloid growth factor in bone marrow adjacent to joints affected by rheumatoid arthritis J Rheumatol 1989;16:5:572-7.
14. Seitz M. Zwicker M, Pichler W, Gerber N: Activation and differentiation of myelomonocytic cells in rheumatoid arthritis and healthy individuals - evidence for antagonistic in vitro regulation by Interferon-γ and tumor necrosis factor α, granulocyte monocyte colony stimulating factor and interleukin 1. J Rheumatol 1992;19:1038-44.
15. Kotake S, Higaki M, Sato K, et al.: Detection of myeloid precursors (granulocyte/macrophagc colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints. J Rheumatol 1992;19:1511-6.
16. Sohen S, Kita H, Tanaka S: Abnormalities in bone marrow monomiclear cells in patients with rheumatoid arthritis. J Rhcumatol 1993;20:12-6.
17. Tomita T, Kashiwagi N, Shimaoka Y, et al. Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis. J Rheumatol 1994;21:1608-14.
18. Hamilton JA: Rheumatoid arthritis: Opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 1993;342:536-9.
19. Hirohata S, Yanagida T, Koda M, Koiwa M, Yoshino S, Ochi T: Selective induction of IgM rheumatoid factors by CD 14+ motiocytelineage cells generated from bone marrow of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:384-8.
20. Bender JG, Unverzagt KL, Walker DE, et al.: Identification and comparison of CD34-posstive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991;77:2591-6.
21. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C: "Pure" human hematopoietic progenitors: Permissive action of basic fibroblast growth factor. Science 1990;249:1561-4.
22. Serke S, Abe Y, Kirsch A, Huhn D: Phenotyping of peripheral blood hemopoietic progenitor cells-in vitro cultures using CD34-/CD33-immunomagnetic purging. Eur J Haematol 1991;47:361-6.
23. Henon PR: Peripheral blood stem cell transplantations: Past, present, and future. Stem Cells 1993;11:154-72.
24. Craig JIO, Anthony RS, Parker AC: Circulating progenitor cells in myelofibrosis: The effect of recombinant α2b mterferon in vivo and in vitro. Br J Haematal 1991;78:155-60.
25. Takaue Y, Kawano Y. Reading CL, et al.: Effects of recombinant human G-CSF, GM-CSF, IL-3. and IL-la on the growth of purified human peripheral blood progenitors. Blood 1990;76:330-5
26. Lord BI, Gurney H, Chang J, Thatcher N, Crowther D, Dexter TM: Haemopoietic cell kinetics in humans treated with rGM-CSF. Int J Cancer 1992;50:26-31.
27. Herrmann F, Brugger W, Kanz L, Mittelsmann R: In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells. Semin Oncology 1992;19:422-31.
28. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK: Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003-10.
29. Tjonnfjord GE, Steen R, Evensen SA, Thorsby E, Egeland T: Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994;84:2795-801.
30. Chatta GS, Price TH, Allen RC, Dale DC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers Blood 1994;84:9:2923-9.
31. Firestein GS, Alvaro-Garcia JM, Maki R: Quantitative analysis of cytoktne gene expression in rheumatoid arthritis. J Immunol 1990.144:9:3347-53
32. Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24
33. Santiago-Schwarz F, Kay C, Panagiotopoulos C, Carsons SE: Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor. J Rheumatol 1992;19:223-8.
34. Vitali C. Bombardieri S, Moutsopoulos HM, et al.: Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
35. Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR: Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1997;77:1218-27.
36. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 1992;52:274-81.
37. Santiago-Schwarz F, Divaris N, Kay C, Carsons SE: Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimuiatmg factor-induced dendritic cell development. Blood 1993;82:3019-28.
38. Ulich TR, del Castillo J, McNiece IK, et al.: Stem cell factor in combination with gramilocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo. Blood 1991;78:1954-62.
39. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Huffman R: Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 1992;79:634-41.
40. Talal N, Moutsopoulos HM, Kassen SS, eds: Sjögren's Syndrome. Clinical and Immunological Aspects. Berlin: Springer-Verlag, 1987.
41. Smith MD. Lamour A, Boylston A, et al.: Selective expression of VB families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndrome. J Rheumatol 1994;21:1832-7.
42. Llorente L, Richaudpatin Y, Fior R, et al.: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus - A potential mechanism of B lymphocyte hyperactivity and autoimmumty. Arthritis Rheum 1994;37:1647-55.
43. Howell A, Gumpel JM, Watts RWE: Depression of bone marrow colony formation in gold-induced neutropenia. BMJ 1975;1:432-4.
44. Pietschmann P, Cush JJ, Lipsky PE, Oppenheimer-Marks N: Identification of subsets of human T-cells capable of enhanced transendothelial migration. J Immunol 1992;149:1170-8.
45. lannone F, Comgall VM, Kingsley GH, Panayi GS: Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 1994;24:2706-13.
46. Fox RI, Theofilopoulos AN, Altman A: Production of interleukin 2 (IL-2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptide of IL-2. J Immunol 1985;135:3109-15.
47. Fox RI, Hugli TE, Lanier LL, Morgan EL, Howell F: Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by leu-7 and leu-11 antigens. J Immunol 1985;135:207-14.
48. Gerli R, Bertotto A, Agea E, et al.: Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome. J Cjin Invest 1990;86:1870-7.